SCHLAGWORTE: Innovation and Start-up Center for Biotechnology
Heading for clinical breakthrough backed by a broad investor base
Tubulis wants to improve the efficacy of cancer therapies by using antibody drug conjugates (ADCs). Three pipeline products are currently in clinical development. ‘We...